Hepatocellular carcinoma (HCC) is one of the most common cancers in the world and the third leading cause of cancer deaths. HCC has a high mortality rate with a five-year survival rate of less than 5percent, with or without therapeutic interventions. The infection by hepatitis B virus (HBV) and hepatitis C virus (HCV) accounts for 75-85 percent of the HCC cases. The goal of this Program Project Grant (PPG) application is to investigate how HBV and HCV induce HCC and the host genetic factors that may be involved in these oncogenic processes. In addition, we will also explore novel therapeutic options for the treatment of HCC patients. There are four component projects and one Administrative Core in this PPG. The Administrative Core will be responsible for the administrative and budgetary issues and the four component projects are to study: Project 1: Transgenic mice as a model system for HBV replication and oncogenesis Project 2: Hepatic carcinogenesis induced by hepatitis B virus preS2 mutant Project 3: Hepatocarcinogenesis and skin disease by c-jun/Stat3 and repair deficiency in HCV Project 4: SAMe: a novel therapy for hepatocellular cancer The first three projects use animals and cell cultures as model systems to study how HBV and HCV cause HCC. The fourth project focuses on human subjects to study host genetic factors and therapeutic options. These component projects complement one another. Their research interactions will create a productive synergism that will generate research results for the comprehensive understanding of the molecular etiology of HCC and for the possible development of novel therapeutic options for HCC patients.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RPRB-O (J1))
Program Officer
Read-Connole, Elizabeth Lee
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Southern California
Schools of Medicine
Los Angeles
United States
Zip Code
Machida, Keigo (2017) Existence of cancer stem cells in hepatocellular carcinoma: myth or reality? Hepatol Int 11:143-147
Tian, Y; Kuo, C-F; Sir, D et al. (2015) Autophagy inhibits oxidative stress and tumor suppressors to exert its dual effect on hepatocarcinogenesis. Cell Death Differ 22:1025-34
Chen, Chia-Lin; Tsukamoto, Hidekazu; Liu, Jian-Chang et al. (2013) Reciprocal regulation by TLR4 and TGF-? in tumor-initiating stem-like cells. J Clin Invest 123:2832-49
Czaja, Mark J; Ding, Wen-Xing; Donohue Jr, Terrence M et al. (2013) Functions of autophagy in normal and diseased liver. Autophagy 9:1131-58
Tian, Yongjun; Kuo, Cheng-fu; Chen, Wen-ling et al. (2012) Enhancement of hepatitis B virus replication by androgen and its receptor in mice. J Virol 86:1904-10
Wang, Qian; Na, Bing; Ou, Jing-hsiung James et al. (2012) Hepatitis B virus alters the antioxidant system in transgenic mice and sensitizes hepatocytes to Fas signaling. PLoS One 7:e36818
Tian, Yongjun; Chen, Wen-ling; Kuo, Cheng-fu et al. (2012) Viral-load-dependent effects of liver injury and regeneration on hepatitis B virus replication in mice. J Virol 86:9599-605
Feldman, Douglas Edmund; Chen, Chialin; Punj, Vasu et al. (2012) Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells. Proc Natl Acad Sci U S A 109:829-34
Tang, Chi-Hui; Wei, Wei; Liu, Limin (2012) Regulation of DNA repair by S-nitrosylation. Biochim Biophys Acta 1820:730-5
Sir, Donna; Kuo, Cheng-fu; Tian, Yongjun et al. (2012) Replication of hepatitis C virus RNA on autophagosomal membranes. J Biol Chem 287:18036-43

Showing the most recent 10 out of 25 publications